查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1853471

微创胸腔外科手术市场按手术类型、产品、最终用户、技术和应用划分－2025-2032年全球预测

Minimally Invasive Thoracic Surgery Market by Procedure Type, Product, End User, Technology, Application - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 182 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2032 年，微创胸腔外科手术市场规模将达到 51.8 亿美元，复合年增长率为 8.30%。

主要市场统计数据
基准年 2024 27.3亿美元
预计年份：2025年 29.6亿美元
预测年份：2032年 51.8亿美元
复合年增长率 (%) 8.30%

一个简洁的框架展示了程序、产品和机构动态如何融合，从而重新定义胸腔外科的病患诊疗路径和临床重点。

胸腔外科微创手术已进入一个新阶段，手术流程、技术和医疗机构的优先事项相互交织，共同重塑手术模式和病患预后。过去十年，外科医生和医院系统不断扩大微创技术的应用范围，以降低手术全期併发症发生率、缩短復原时间并提高病患满意度。这项转变不仅反映了不断发展的临床证据，也得益于可视化技术、器械和平台整合方面的进步，使得复杂的胸腔外科手术能够以更小的网路基地台和更高的精准度完成。

事实上，手术类型已扩展至多种选择，从机器人辅助胸腔镜手术到单孔入路和传统视讯辅助手术，每种手术方式都存在不同的临床权衡和工作流程影响。同时，产品创新集中在能量设备、精密器械、缝合系统和先进的可视化解决方案，从而为手术团队建立了一个丰富的生态系统，以优化手术流程和结果。最终使用者的动态受到门诊手术中心对高效当日手术流程的需求的影响，而医院则继续在区域手术需求和三级医疗的复杂性之间寻求平衡。技术架构涵盖多孔、单孔和机器人系统，以满足机构在成本、可扩展性和临床适用性等方面的优先事项。

随着相关人员考虑投资和实施策略，他们越来越关注手术选择、设备相容性和设施准备如何共同决定治疗路径。本执行摘要整合了这些相互影响的因素，并为寻求将创新与永续临床价值相结合的临床领导者、医院管理者、设备製造商和政策制定者提供了启示。

整合平台的发展、流程的演变以及分散式医疗模式如何重塑胸腔外科手术实践和采购选择

胸腔外科领域正经历一场变革，这场变革是由技术、临床和操作趋势的整合所驱动的。首先，机器人平台的成熟透过提高操作的灵活性和三维视觉化能力，改变了复杂切除手术的格局，从而拓展了以往微创手术的适应症。单孔技术的改进和视讯辅助内视镜技术的增强，进一步推动了这一发展，使外科医生能够根据自身的临床目标和机构能力选择合适的手术方案。

其次，器械层面的创新正在加速从单一功能工具向整合系统的转变，这些系统将能量传输、精准解剖和缝合钉放置整合到一致的手术流程中。先进的双极和超音波能量器械能够有效止血和处理组织，从而减少附带热损伤并缩短手术时间。提供高清影像和三维内视镜的视觉化系统改善了术中决策，并减少了对开放性手术的依赖。诸如抓钳、分离器和专用剪刀等器械经过反覆优化，在不影响人体工学的前提下，支持减少手术切口和单孔入路的策略。

第三，医疗服务模式正变得日益分散化，门诊手术中心和社区医院进行难度较低的胸腔外科手术，而三级医疗中心则专注于难度较高的病例和复杂的重组手术。这种医疗服务的重新分配要求产品系列和培训路径能够支援在不同环境下的可扩展应用。最后，监管机构的关注和支付方的审查促使製造商和医疗服务提供者证明手术本身的价值、安全性和可重复性。这些转变并非渐进式的，而是系统性的；它们正在改变介入措施的设计、实施和报销方式，迫使相关人员重新思考临床通讯协定、资金分配和培训投资。

为因应关税变化对采购、製造伙伴关係和合约价值模式的影响，供应链调整和筹资策略正在改变。

将于2025年生效的关税调整，是影响整个医疗保健生态系统供应链策略、采购时机和成本转嫁的重要外部因素。为此，製造商和医疗机构的采购团队正在重新审视其采购布局和库存策略，以减轻进口关税上涨的影响，并确保关键物资的持续供应。这促使他们更加关注近岸外包、供应商网路多元化以及重新谈判合约条款，并更加重视总体拥有成本而非仅仅关注单价。

除了供应商选择之外，临床医生和手术室管理人员也开始评估产品的模组化和可重复使用性，作为在成本限制更加严格的情况下维持手术能力的手段。例如，支援更广泛器械和耗材的系统，透过减少对多种单一用途器械的需求，提高了采购效率。同时，关税主导的价格调整的可能性，也促使设备製造商和医院集团之间就批量采购和基本契约展开更深入的合作对话。这些安排既能实现风险共担，又能确保获得维持临床品质所需的先进医疗设备。

重要的是，关税环境正在加速围绕本地製造伙伴关係和技术转移协议的策略决策。相关人员越来越重视在低关税地区建立组装和零件製造工厂，以保护净利率并稳定供应。虽然这些营运模式的转变不会改变临床适应症或外科手术创新的发展轨迹，但它们将改变新工具在不同地区推广的速度，以及哪些供应商会成为医院系统和门诊手术中心的长期策略伙伴。

深入分析细分相关流程选择、设备模式细微差别、设施要求和特定应用临床需求，以阐明其应用。

细分市场分析提供了一个视角，帮助我们了解不同手术类型、产品类型、最终用户、技术和应用领域的采用模式、临床适用性和购买行为。在选择手术类型时，临床医生会权衡机器人辅助胸腔镜手术、单孔胸腔镜手术和视频辅助胸腔镜手术之间的利弊，并平衡精度、学习曲线和手术室占用空间等因素，以确定哪种手术最适合其所在机构的病例组合。能量设备（例如先进的双极电凝系统、电凝器和超音波系统）的选择是基于其止血性能和温度曲线，而器械（例如分离器、抓钳和剪刀）则需评估其人体工学设计以及与手术入路和手术方式的兼容性。缝合器和抛弃式仍然是组织切割和吻合的必需品，而从高解析度平台到3D内视镜和2D内视镜等视觉化系统，对术中决策和训练路径有着显着的影响。

终端使用者细分突显了门诊手术中心和医院的不同需求。门诊手术中心优先考虑精简的工作流程、快速的周转和经济高效的抛弃式，而医院（包括社区医院和三级医疗中心）则需要可扩展性，以支持复杂的手术切除、多学科团队以及术后强化护理。技术细分錶明，多孔、机器人和单孔系统在资金投入、维护和培训方面各有不同，这会影响采购时间表和部署策略。最后，将应用场景分为诊断和治疗两类，揭示了仪器和视觉化选择如何取决于主要目标是精确定位病灶还是进行治疗性切除和重组。

综合来看，市场区隔表明，竞争定位取决于满足跨领域的要求，例如临床疗效、设备在不同手术方法中的兼容性、减少采用障碍的服务和培训产品，以及能够引起门诊中心和大型医院共鸣的价值提案。

在全球市场中，医疗保健系统和采购现实的区域差异如何影响技术采纳、培训重点和商业化策略

美洲、欧洲、中东和非洲以及亚太地区的区域动态正在影响技术的扩散、报销管道和普及率，而每个区域都有其独特的结构性驱动因素。在美洲营运的相关人员常常面临复杂的环境：先进的三级医疗中心引领机器人和单孔器材的普及，而社区医院和门诊中心则在评估经济高效的器材平台，以扩大微创手术的覆盖范围。该地区的报销模式影响着采购週期以及对有望提高营运效率的资本密集系统的投资意愿。

在欧洲、中东和非洲，医疗体系组织和采购实务的差异导致了医疗技术应用路径的多样性。有些市场强调集中采购和国家层级的临床效用评估，在证据充分的情况下加速推广应用；而有些市场则因成本效益检验不足而延后应用。同时，中东部分私人医疗机构正迅速采用高端平台，以满足病患对先进医疗服务的需求。在亚太地区，大型手术中心和快速发展的区域性医院共同推动了复杂视频辅助手术的普及，并在手术量足以支撑资本支出的情况下，对机器人手术平台的兴趣日益浓厚。该地区的供应链韧性和在地化生产措施也在塑造商业策略和服务模式方面发挥关键作用。

整体而言，区域策略必须根据当地的报销结构、训练体系成熟度和医疗机构能力量身订做。能够提供符合当地实际情况的产品组合、服务覆盖范围和培训项目的供应商和医疗系统，将能够有效地渗透多元化市场，并支持可持续的推广管道。

竞争格局分析：揭示平台现有企业、专业创新和伙伴关係主导的策略，这些策略共同定义了差异化的市场定位。

该领域的竞争格局由成熟的平台供应商、专业设备製造商以及专注于能量、缝合和可视化技术的创新新兴企业组成。专业公司透过专注于差异化的性能属性，例如精密的能量曲线、超薄缝合技术和超高清3D成像，在特定手术领域不断扩大市场份额。

随着企业寻求平台存取和一流耗材，合作模式日益普遍。伙伴关係和培训生态系统是关键的竞争优势，缩短学习曲线并提供稳定结果的能力会影响医院和门诊中心的采购决策。此外，提供涵盖模拟培训、测试监督和性能分析等全面支持项目的製造商，将自身定位为临床品质改进的合作伙伴，而不仅仅是供应商。

新参与企业正透过满足尚未充分满足的需求来开闢市场，例如面向门诊环境的低成本设备以及针对单埠工作流程最佳化的紧凑型视觉化系统。同时，现有企业则利用装置量、长期服务合约以及数据主导的疗效证据来巩固自身地位。这些动态意味着，竞争优势将越来越取决于企业能否打造整合设备效能、临床培训和商业性弹性的端到端价值提案。

为设备开发商和医疗保健系统提供可操作的策略重点，以将技术能力转化为持续的临床应用和商业性韧性。

产业领导者应优先考虑将技术开发、商业模式和临床应用管道结合的策略，以加速永续推广。首先，投资于互通性和模组化架构，使设备和耗材能够在多个平台和手术方法中使用，将降低医院的转换成本，并促进在区域和三级医疗机构的广泛部署。其次，开发结合模拟、指导和开发后分析的完善的培训和认证项目，将缩短外科医生采用机器人手术、单孔手术或高级视讯辅助手术的学习曲线。

第三，我们将与医院和门诊中心采取灵活的合约模式，纳入配套服务、结果挂钩条款和风险分担机制。此类商业性创新将有助于缓解预算压力，并建立可持续的采购关係。第四，我们将透过调整产品组合和支援服务，使其与当地的报销制度和供应链相适应，从而加强本地市场推广策略。最后，我们将致力于收集和发布真实世界的临床结果，以证明无论手术类型或技术如何，其疗效和安全性均具有可比性，从而支持临床应用和与支付方的对话。

透过实施这些策略重点，产业领导者可以将技术能力转化为持久的临床影响，同时解决影响医院和门诊病人采购决策的营运和预算限制。

采用综合混合方法，结合关键相关人员参与、临床证据审查、设备评估和供应链分析，以获取可操作的情报。

本初步研究采用混合方法，结合了主要相关人员访谈、临床文献回顾、器械技术评估和供应链分析，以全面了解微创胸腔外科手术。主要访谈对象包括外科负责人、医院采购主管、门诊手术中心管理人员和器械公司产品经理，旨在了解实际决策标准、推广障碍和服务期望。临床文献回顾着重于比较研究、手术流程描述和安全性分析，以了解手术选择如何影响手术结果和工作流程。

设备评估检视了设计特点、互通性、服务模式和培训方案，以评估产品规格如何影响其在不同环境下的应用。供应链和采购分析检视了筹资策略、关税覆盖范围和区域製造因素，以确定相关人员用于管理成本和业务连续性风险的营运手段。在条件允许的情况下，研究结果透过多重资料来源进行三角验证，以检验模式并最大限度地减少单一资料来源的偏差。

在整个调查方法中，我们较少关注产生说明清单，而更注重提取可操作的情报以支援策略决策。此方法的局限性包括报告惯例的区域差异以及各机构对程序结果看法的不同，但我们透过优先考虑三角验证和专家检验来解决这些问题。

面向未来的整合方案，强调设备设计、临床培训和商业性适应性的整合，以确保广泛且持续的应用。

总之，微创胸腔外科手术正处于曲折点，器械创新、手术流程改善和医疗服务模式的转变共同塑造未来的发展方向。手术方式的选择、产品性能和医疗机构的准备之间的相互作用，不仅决定临床结果，也决定技术应用的速度和规模。随着供应链压力和关税变化对商业动态的影响，相关人员必须采取统筹兼顾采购、培训和临床管治的整体策略。

展望未来，最成功的机构将是那些整合模组化产品设计、强大的服务和培训体係以及在地化商业模式的机构。透过优先考虑互通性、真实世界证据的生成以及灵活的合约条款，製造商和医疗服务提供者可以在控制财务和营运风险的同时，支持微创胸腔外科手术的广泛普及。最终目标是确保临床进展能够转化为患者照护的可衡量改进，并惠及从门诊中心到三级医院等各种医疗机构。

目录

第一章：序言

第二章调查方法

第三章执行摘要

第四章 市场概览

第五章 市场洞察

  • 提高单孔胸腔镜辅助手术技术的应用率，以缩短患者復健时间
  • 结合影像导引与人工智慧技术，实现高精度微创肺肿瘤切除
  • 扩增实境导航系统的出现可改善胸腔外科手术中外科医师的视野
  • 研发能够以最小创伤到达难以触及的肺结节的柔性内视镜器械。
  • 在微创胸腔外科手术中增加门诊和当日出院通讯协定
  • 能量型密封装置的进步可减少胸腔镜手术中的术中出血
  • 增加远端监控平台的投资，用于虚拟外科医生培训和微创手术技能评估

第六章美国关税的累积影响，2025年

第七章 人工智慧的累积影响，2025年

8. 微创胸腔外科手术市场（依手术类型划分）

  • 机器人辅助胸腔镜手术
  • Uniportal VATS
  • 视讯辅助胸腔镜手术

第九章 微创胸腔外科市场：依产品划分

  • 能源设备
    • 先进的双极元件
    • 电灼
    • 超音波
  • 装置
    • 解剖器
    • 抓钳
    • 剪刀
  • 订书机和一次性用品
  • 视觉化系统
    • 高解析度系统
    • 三维内视镜
    • QR 图内视镜

第十章 依最终用户分類的微创胸腔外科手术市场

  • 门诊手术中心
  • 医院
    • 社区医院
    • 三级医疗中心

第十一章 微创胸腔外科市场：依技术划分

  • 多埠系统
  • 机器人系统
  • 单埠系统

第十二章 微创胸腔外科市场：依应用领域划分

  • 诊断
  • 治疗

第十三章 微创胸腔外科市场：依地区划分

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十四章 微创胸腔外科市场（依集团划分）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十五章 各国微创胸腔外科手术市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十六章 竞争格局

  • 2024年市占率分析
  • FPNV定位矩阵，2024
  • 竞争分析
    • Intuitive Surgical, Inc.
    • Johnson & Johnson
    • Medtronic plc
    • Smith & Nephew plc
    • Stryker Corporation
    • Olympus Corporation
    • Boston Scientific Corporation
    • B. Braun Melsungen AG
    • KARL STORZ SE & Co. KG
    • CONMED Corporation
Product Code: MRR-3A2E844FEF43

The Minimally Invasive Thoracic Surgery Market is projected to grow by USD 5.18 billion at a CAGR of 8.30% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 2.73 billion
Estimated Year [2025] USD 2.96 billion
Forecast Year [2032] USD 5.18 billion
CAGR (%) 8.30%

Concise framing of how procedural, product, and institutional dynamics converge to redefine patient pathways and clinical priorities in thoracic surgery

Minimally invasive approaches to thoracic surgery have entered a phase where technique, technology, and institutional priorities intersect to reshape surgical pathways and patient outcomes. Over the past decade, surgeons and hospital systems have steadily expanded adoption of less invasive procedures to reduce perioperative morbidity, shorten recovery timelines, and improve patient satisfaction. This shift reflects not only evolving clinical evidence but also advances in visualization, instrumentation, and platform integration that enable complex thoracic procedures to be executed with smaller access points and enhanced precision.

In practice, procedure type choices have broadened to include an array of options-ranging from robotic assisted thoracoscopic surgery to uniportal approaches and conventional video-assisted techniques-each offering distinct clinical trade-offs and workflow implications. Concurrently, product innovation has centered on energy devices, refined instruments, staple systems and advanced visualization solutions, creating a richer ecosystem for surgical teams to optimize techniques and outcomes. End-user dynamics have been shaped by ambulatory surgical centers seeking efficient, same-day workflows while hospitals continue to balance community-level procedural demand with tertiary care complexity. Technology architectures, spanning multi-port to single-port and robotic systems, respond to institutional priorities for cost, scalability, and clinical versatility.

As stakeholders evaluate investment and adoption strategies, attention increasingly falls on how procedural selection, device compatibility, and facility readiness converge to define pathways of care. This executive summary synthesizes those converging forces and frames implications for clinical leaders, hospital administrators, device manufacturers, and policy-makers aiming to align innovation with sustainable clinical value.

How integrated platform advancements, procedural technique evolution, and care model decentralization are jointly reshaping thoracic surgery practice and procurement choices

The landscape for thoracic surgery is undergoing transformative shifts driven by converging technological, clinical, and operational trends. First, maturation of robotic platforms has altered the calculus for complex resections by improving dexterity and three-dimensional visualization, which in turn has expanded indications where minimally invasive approaches were previously constrained. This evolution is complemented by refinement in uniportal techniques and enhancements in video-assisted endoscopy, enabling surgeons to select an approach that matches clinical goals and institutional capacity.

Second, device-level innovation has accelerated the transition from single-function tools to integrated systems that combine energy delivery, precision dissection, and stapling within a cohesive procedural workflow. Advanced bipolar and ultrasonic energy modalities address hemostasis and tissue handling in ways that reduce collateral thermal injury and streamline operative time. Visualization systems that provide high-definition imaging and 3D endoscopes have improved intraoperative decision-making and reduced reliance on open conversions. Instruments such as graspers, dissectors, and specialized scissors have been iteratively optimized to support port reduction strategies and single-site access without compromising ergonomics.

Third, care delivery models are shifting toward greater decentralization, with ambulatory surgical centers and community hospitals increasingly performing lower-complexity thoracic procedures while tertiary centers focus on high-acuity cases and complex reconstructions. This redistribution of care necessitates product portfolios and training pathways that support scalable adoption across diverse settings. Finally, regulatory attention and payer scrutiny are prompting manufacturers and providers to demonstrate procedure-level value, safety, and reproducibility. Taken together, these shifts are not incremental but systemic: they change how interventions are designed, delivered, and reimbursed, compelling stakeholders to reassess clinical protocols, capital allocation, and training investments.

Supply chain adaptations and procurement strategies responding to tariff shifts that influence sourcing, manufacturing partnerships, and contractual value models

Tariff changes effective in 2025 represent an important external driver influencing supply chain strategy, procurement timing, and cost pass-through across the healthcare ecosystem. In response, manufacturers and institutional purchasing teams have been reassessing sourcing footprints and inventory policies to mitigate exposure to increased import duties and to maintain continuity of critical supplies. This has prompted heightened interest in nearshoring options, diversified supplier networks, and renegotiated contractual terms that emphasize total cost of ownership rather than unit price alone.

Beyond supplier selection, clinicians and operating room managers have begun to evaluate product modularity and reusability as levers to preserve procedural capacity under tighter cost constraints. For example, systems that support a broader range of instruments and consumables offer purchasing efficiencies by reducing the need for multiple single-purpose devices. At the same time, the potential for tariff-driven price adjustments has strengthened collaborative dialogues between device companies and hospital groups about bundled procurement and value-based contracting. These arrangements allow risks to be shared while ensuring access to advanced devices necessary for maintaining clinical quality.

Importantly, the tariff environment also accelerates strategic decisions around local manufacturing partnerships and technology transfer agreements. Stakeholders are increasingly weighing the benefits of establishing assembly or component production within lower-tariff jurisdictions to protect margins and stabilize supply. While these operational shifts do not alter clinical indications or the trajectory of surgical innovation, they do change how quickly new tools are adopted across regions and which suppliers become strategic long-term partners for hospital systems and ambulatory centers alike.

Deep-dive segmentation perspective linking procedural choices, device modality nuances, institutional requirements, and application-specific clinical demands for adoption clarity

Segment analysis provides a lens to understand differentiated adoption patterns, clinical suitability, and purchasing behavior across procedure types, products, end users, technologies, and applications. When examining procedure types, clinicians weigh the trade-offs among robotic assisted thoracoscopic surgery, uniportal VATS, and video-assisted thoracoscopic surgery, balancing factors such as precision, learning curve, and operating room footprint to determine the right fit for institutional case mix. Product portfolios require similar nuance: energy devices including advanced bipolar, electrocautery, and ultrasonic systems are selected based on hemostatic performance and thermal profile, while instruments such as dissectors, graspers, and scissors are assessed for ergonomics and compatibility with port size and approach. Staplers and disposables remain essential for tissue transection and anastomosis, and visualization systems from high-definition platforms to three-dimensional endoscopes and two-dimensional options materially affect intraoperative decision-making and training pathways.

End-user segmentation highlights divergent needs between ambulatory surgical centers and hospitals, where ambulatory settings prioritize streamlined workflows, rapid turnover, and cost-effective disposables, whereas hospitals - encompassing both community hospitals and tertiary care centers - require scalability to support complex resections, multidisciplinary teams, and intensive postoperative care. Technology segmentation illuminates how multi-port systems, robotic systems, and single-port systems each present different capital, maintenance, and training profiles that influence procurement timelines and deployment strategies. Lastly, the application split between diagnostic and therapeutic use cases underscores how instrumentation and visualization choices are driven by whether the primary objective is precise lesion localization or therapeutic resection and reconstruction.

Taken together, segmentation reveals that competitive positioning depends on addressing cross-cutting requirements: clinical efficacy, instrument compatibility across procedural approaches, service and training offerings that reduce the barrier to adoption, and value propositions that resonate with both ambulatory centers and high-volume tertiary hospitals.

How regional healthcare system variation and procurement realities govern technology adoption, training priorities, and commercialization strategies across global markets

Regional dynamics shape technology diffusion, reimbursement pathways, and adoption velocity across the Americas, Europe, Middle East & Africa, and Asia-Pacific, each presenting distinct structural drivers. Stakeholders operating in the Americas often encounter a mixed environment where advanced tertiary centers lead in robotic and single-port adoption while community hospitals and ambulatory centers evaluate cost-effective instrument platforms to expand minimally invasive access. Reimbursement models in this region influence purchasing cycles and the willingness to invest in capital-intensive systems that promise operational efficiencies.

In Europe, Middle East & Africa, variation in health system organization and procurement practices creates a mosaic of adoption trajectories. Some markets emphasize centralized procurement and national-level assessments of clinical benefit, which can either accelerate uptake when evidence is favorable or slow adoption pending cost-effectiveness reviews. Meanwhile, private healthcare segments in parts of the Middle East display rapid uptake of premium platforms aligned with patient demand for advanced care. Across Asia-Pacific, a mix of high-volume surgical centers and rapidly maturing community hospitals drives parallel adoption of refined video-assisted techniques and an increasing interest in robotic platforms where surgical volumes justify the capital outlay. Supply chain resilience and local manufacturing initiatives in this region also play a significant role in shaping commercial strategies and service models.

Overall, regional strategies must be tailored to local reimbursement structures, training ecosystem maturity, and facility-level capabilities. Vendors and health systems that align product configurations, service footprints, and training programs with regional realities can more effectively penetrate diverse markets and support sustainable adoption pathways.

Competitive landscape insights revealing platform incumbency, specialist innovation, and partnership-led strategies that define differentiated market positioning

Competitive dynamics in this field reflect a mix of established platform providers, specialist instrument manufacturers, and emerging firms offering focused innovations in energy, stapling, and visualization. Leading platform providers continue to invest in modularity and interoperability to reduce lock-in and broaden clinical reach, while specialist companies focus on differentiated performance characteristics-such as refined energy profiles, low-profile stapling technologies, or ultra-high-definition three-dimensional imaging-to capture share within specific procedure segments.

Partnerships and collaboration models have become increasingly common as companies seek to combine platform access with best-in-class consumables. Service and training ecosystems are crucial competitive differentiators, as the ability to reduce the learning curve and deliver consistent outcomes influences purchasing decisions by hospitals and ambulatory centers. Moreover, manufacturers that offer comprehensive support programs covering simulation training, proctoring, and performance analytics position themselves as partners in clinical quality improvement rather than mere suppliers.

New entrants are carving out niches by addressing underserved needs, such as cost-sensitive instruments for ambulatory settings or compact visualization systems optimized for single-port workflows. At the same time, incumbents defend their positions by leveraging installed bases, long-term service agreements, and data-driven outcomes evidence. These dynamics mean that competitive advantage increasingly depends on the ability to craft end-to-end value propositions that integrate device performance, clinical training, and commercial flexibility.

Actionable strategic priorities for device developers and health systems to translate technological capability into durable clinical adoption and commercial resilience

Industry leaders should prioritize strategies that align technology development, commercial models, and clinical adoption pathways to accelerate sustainable uptake. First, invest in interoperability and modular architectures that enable instruments and consumables to be used across multiple platforms and procedural approaches, thereby reducing switching costs for hospitals and encouraging broader deployment in community and tertiary settings. Secondly, develop robust training and credentialing programs that combine simulation, proctoring, and post-market analytics to shorten the learning curve for surgeons adopting robotic, uniportal, or advanced video-assisted techniques.

Third, pursue flexible contracting approaches with hospitals and ambulatory centers that incorporate bundled services, outcome-linked clauses, and shared risk elements. These commercial innovations can help mitigate budgetary pressures and create durable procurement relationships. Fourth, strengthen regional go-to-market strategies by tailoring product configurations and support services to local reimbursement realities and supply chain considerations; this is particularly important in markets where local manufacturing partnerships or assembly can materially improve cost competitiveness. Finally, commit to collecting and publishing real-world outcomes that demonstrate comparative effectiveness and safety across procedure types and technologies, which will support clinical adoption and payer dialogues.

By executing these strategic priorities, industry leaders can convert technological capability into sustained clinical impact while addressing the operational and budgetary constraints that influence hospital and ambulatory purchasing decisions.

Integrated mixed-methods approach combining primary stakeholder engagement, clinical evidence review, device assessment, and supply chain analysis for actionable intelligence

This research synthesis draws on a mixed-methods approach combining primary stakeholder interviews, clinical literature review, device and technology assessments, and supply chain analysis to produce an integrated perspective on minimally invasive thoracic surgery. Primary interviews included surgical leaders, hospital procurement executives, ambulatory center administrators, and product managers from device firms to capture real-world decision criteria, adoption barriers, and service expectations. Clinical literature review focused on comparative studies, technique descriptions, and safety analyses to understand how procedural choices map to outcomes and workflow implications.

Device assessments examined design attributes, interoperability, service models, and training offerings to evaluate how product specifications influence adoption in different settings. Supply chain and procurement analyses explored sourcing strategies, tariff exposure, and regional manufacturing considerations to identify operational levers that stakeholders use to manage cost and continuity risk. Where possible, findings were triangulated across data sources to validate patterns and minimize single-source bias.

Throughout the methodology, emphasis was placed on extracting actionable intelligence that supports strategic decision-making rather than producing descriptive lists. Limitations of the approach include variability in regional reporting practices and differences in how institutions capture procedural outcomes, which were addressed by prioritizing triangulated insights and expert validation.

A forward-looking synthesis emphasizing integration of device design, clinical training, and commercial adaptability to ensure broad and sustainable adoption

In sum, minimally invasive thoracic surgery is at an inflection point in which device innovation, procedural refinement, and shifting care delivery models collectively shape the path forward. The interplay among procedure type selection, product capabilities, and institutional readiness determines not only clinical outcomes but also the speed and scale of technology adoption. As supply chain pressures and tariff changes influence commercial dynamics, stakeholders must adopt holistic strategies that align procurement, training, and clinical governance.

Looking ahead, the most successful organizations will be those that integrate modular product design, strong service and training ecosystems, and regionally attuned commercial models. By prioritizing interoperability, real-world evidence generation, and flexible contracting, manufacturers and providers can support broader access to minimally invasive thoracic techniques while managing financial and operational risk. Ultimately, the goal is to ensure that clinical advances translate into measurable improvements in patient care across diverse settings, from ambulatory centers to tertiary hospitals.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Expanding adoption of uniportal video-assisted thoracic surgery techniques to reduce patient recovery time
  • 5.2. Integration of artificial intelligence-driven imaging guidance for precise minimally invasive lung tumor resections
  • 5.3. Emergence of augmented reality navigation systems enhancing surgeon visualization in thoracic procedures
  • 5.4. Development of flexible endoscopic instruments enabling access to hard-to-reach pulmonary nodules with minimal trauma
  • 5.5. Growth of outpatient and same-day discharge protocols in minimally invasive thoracic surgery settings
  • 5.6. Advancements in energy-based sealing devices reducing intraoperative bleeding during thoracoscopic interventions
  • 5.7. Increasing investments in remote proctoring platforms for virtual surgeon training and skill assessment in MIS

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Minimally Invasive Thoracic Surgery Market, by Procedure Type

  • 8.1. Robotic Assisted Thoracoscopic Surgery
  • 8.2. Uniportal Vats
  • 8.3. Video Assisted Thoracoscopic Surgery

9. Minimally Invasive Thoracic Surgery Market, by Product

  • 9.1. Energy Devices
    • 9.1.1. Advanced Bipolar
    • 9.1.2. Electrocautery
    • 9.1.3. Ultrasonic
  • 9.2. Instruments
    • 9.2.1. Dissectors
    • 9.2.2. Graspers
    • 9.2.3. Scissors
  • 9.3. Staplers & Disposables
  • 9.4. Visualization Systems
    • 9.4.1. High Definition Systems
    • 9.4.2. Three D Endoscopes
    • 9.4.3. Two D Endoscopes

10. Minimally Invasive Thoracic Surgery Market, by End User

  • 10.1. Ambulatory Surgical Centers
  • 10.2. Hospitals
    • 10.2.1. Community Hospitals
    • 10.2.2. Tertiary Care Centers

11. Minimally Invasive Thoracic Surgery Market, by Technology

  • 11.1. Multi Port Systems
  • 11.2. Robotic Systems
  • 11.3. Single Port Systems

12. Minimally Invasive Thoracic Surgery Market, by Application

  • 12.1. Diagnostic
  • 12.2. Therapeutic

13. Minimally Invasive Thoracic Surgery Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Minimally Invasive Thoracic Surgery Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Minimally Invasive Thoracic Surgery Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2024
  • 16.2. FPNV Positioning Matrix, 2024
  • 16.3. Competitive Analysis
    • 16.3.1. Intuitive Surgical, Inc.
    • 16.3.2. Johnson & Johnson
    • 16.3.3. Medtronic plc
    • 16.3.4. Smith & Nephew plc
    • 16.3.5. Stryker Corporation
    • 16.3.6. Olympus Corporation
    • 16.3.7. Boston Scientific Corporation
    • 16.3.8. B. Braun Melsungen AG
    • 16.3.9. KARL STORZ SE & Co. KG
    • 16.3.10. CONMED Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY PROCEDURE TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY PROCEDURE TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY PRODUCT, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY PRODUCT, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY TECHNOLOGY, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. AMERICAS MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. NORTH AMERICA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. LATIN AMERICA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. EUROPE MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. MIDDLE EAST MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. AFRICA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASEAN MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GCC MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. EUROPEAN UNION MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. BRICS MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. G7 MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. NATO MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. MINIMALLY INVASIVE THORACIC SURGERY MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 30. MINIMALLY INVASIVE THORACIC SURGERY MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. MINIMALLY INVASIVE THORACIC SURGERY MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY ROBOTIC ASSISTED THORACOSCOPIC SURGERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY ROBOTIC ASSISTED THORACOSCOPIC SURGERY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY ROBOTIC ASSISTED THORACOSCOPIC SURGERY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY ROBOTIC ASSISTED THORACOSCOPIC SURGERY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY ROBOTIC ASSISTED THORACOSCOPIC SURGERY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY ROBOTIC ASSISTED THORACOSCOPIC SURGERY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY UNIPORTAL VATS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY UNIPORTAL VATS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY UNIPORTAL VATS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY UNIPORTAL VATS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY UNIPORTAL VATS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY UNIPORTAL VATS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY VIDEO ASSISTED THORACOSCOPIC SURGERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY VIDEO ASSISTED THORACOSCOPIC SURGERY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY VIDEO ASSISTED THORACOSCOPIC SURGERY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY VIDEO ASSISTED THORACOSCOPIC SURGERY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY VIDEO ASSISTED THORACOSCOPIC SURGERY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY VIDEO ASSISTED THORACOSCOPIC SURGERY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY ENERGY DEVICES, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY ENERGY DEVICES, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY ENERGY DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY ENERGY DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY ENERGY DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY ENERGY DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY ENERGY DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY ENERGY DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY ADVANCED BIPOLAR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY ADVANCED BIPOLAR, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY ADVANCED BIPOLAR, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY ADVANCED BIPOLAR, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY ADVANCED BIPOLAR, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY ADVANCED BIPOLAR, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY ELECTROCAUTERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY ELECTROCAUTERY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY ELECTROCAUTERY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY ELECTROCAUTERY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY ELECTROCAUTERY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY ELECTROCAUTERY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY ULTRASONIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY ULTRASONIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY ULTRASONIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY ULTRASONIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY ULTRASONIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY ULTRASONIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY INSTRUMENTS, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY INSTRUMENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY INSTRUMENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY INSTRUMENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY INSTRUMENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY INSTRUMENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY DISSECTORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY DISSECTORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY DISSECTORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY DISSECTORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY DISSECTORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY DISSECTORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY GRASPERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY GRASPERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY GRASPERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY GRASPERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY GRASPERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY GRASPERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY SCISSORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY SCISSORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY SCISSORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY SCISSORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY SCISSORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY SCISSORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY STAPLERS & DISPOSABLES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY STAPLERS & DISPOSABLES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY STAPLERS & DISPOSABLES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY STAPLERS & DISPOSABLES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY STAPLERS & DISPOSABLES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY STAPLERS & DISPOSABLES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY VISUALIZATION SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY VISUALIZATION SYSTEMS, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY VISUALIZATION SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY VISUALIZATION SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY VISUALIZATION SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY VISUALIZATION SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY VISUALIZATION SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY VISUALIZATION SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY HIGH DEFINITION SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY HIGH DEFINITION SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY HIGH DEFINITION SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY HIGH DEFINITION SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY HIGH DEFINITION SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY HIGH DEFINITION SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY THREE D ENDOSCOPES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY THREE D ENDOSCOPES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY THREE D ENDOSCOPES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY THREE D ENDOSCOPES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY THREE D ENDOSCOPES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY THREE D ENDOSCOPES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY TWO D ENDOSCOPES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY TWO D ENDOSCOPES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY TWO D ENDOSCOPES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY TWO D ENDOSCOPES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY TWO D ENDOSCOPES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY TWO D ENDOSCOPES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY COMMUNITY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY COMMUNITY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY COMMUNITY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY COMMUNITY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY COMMUNITY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY COMMUNITY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY TERTIARY CARE CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY TERTIARY CARE CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY TERTIARY CARE CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY TERTIARY CARE CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY TERTIARY CARE CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY TERTIARY CARE CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY MULTI PORT SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY MULTI PORT SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY MULTI PORT SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY MULTI PORT SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY MULTI PORT SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY MULTI PORT SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY ROBOTIC SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY ROBOTIC SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY ROBOTIC SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY ROBOTIC SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY ROBOTIC SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY ROBOTIC SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY SINGLE PORT SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY SINGLE PORT SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY SINGLE PORT SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY SINGLE PORT SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY SINGLE PORT SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY SINGLE PORT SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY DIAGNOSTIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY DIAGNOSTIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY DIAGNOSTIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY DIAGNOSTIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY DIAGNOSTIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY DIAGNOSTIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY THERAPEUTIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY THERAPEUTIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY THERAPEUTIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY THERAPEUTIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY THERAPEUTIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY THERAPEUTIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 175. AMERICAS MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 176. AMERICAS MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 177. AMERICAS MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 178. AMERICAS MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 179. AMERICAS MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 180. AMERICAS MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 181. AMERICAS MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY ENERGY DEVICES, 2018-2024 (USD MILLION)
  • TABLE 182. AMERICAS MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY ENERGY DEVICES, 2025-2032 (USD MILLION)
  • TABLE 183. AMERICAS MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 184. AMERICAS MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY INSTRUMENTS, 2025-2032 (USD MILLION)
  • TABLE 185. AMERICAS MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY VISUALIZATION SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 186. AMERICAS MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY VISUALIZATION SYSTEMS, 2025-2032 (USD MILLION)
  • TABLE 187. AMERICAS MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 188. AMERICAS MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 189. AMERICAS MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 190. AMERICAS MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 191. AMERICAS MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 192. AMERICAS MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 193. AMERICAS MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 194. AMERICAS MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 195. NORTH AMERICA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 196. NORTH AMERICA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 197. NORTH AMERICA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 198. NORTH AMERICA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 199. NORTH AMERICA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 200. NORTH AMERICA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 201. NORTH AMERICA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY ENERGY DEVICES, 2018-2024 (USD MILLION)
  • TABLE 202. NORTH AMERICA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY ENERGY DEVICES, 2025-2032 (USD MILLION)
  • TABLE 203. NORTH AMERICA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 204. NORTH AMERICA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY INSTRUMENTS, 2025-2032 (USD MILLION)
  • TABLE 205. NORTH AMERICA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY VISUALIZATION SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 206. NORTH AMERICA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY VISUALIZATION SYSTEMS, 2025-2032 (USD MILLION)
  • TABLE 207. NORTH AMERICA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 208. NORTH AMERICA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 209. NORTH AMERICA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 210. NORTH AMERICA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 211. NORTH AMERICA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 212. NORTH AMERICA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 213. NORTH AMERICA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 214. NORTH AMERICA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 215. LATIN AMERICA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 216. LATIN AMERICA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 217. LATIN AMERICA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 218. LATIN AMERICA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 219. LATIN AMERICA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 220. LATIN AMERICA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 221. LATIN AMERICA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY ENERGY DEVICES, 2018-2024 (USD MILLION)
  • TABLE 222. LATIN AMERICA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY ENERGY DEVICES, 2025-2032 (USD MILLION)
  • TABLE 223. LATIN AMERICA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 224. LATIN AMERICA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY INSTRUMENTS, 2025-2032 (USD MILLION)
  • TABLE 225. LATIN AMERICA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY VISUALIZATION SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 226. LATIN AMERICA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY VISUALIZATION SYSTEMS, 2025-2032 (USD MILLION)
  • TABLE 227. LATIN AMERICA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 228. LATIN AMERICA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 229. LATIN AMERICA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 230. LATIN AMERICA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 231. LATIN AMERICA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 232. LATIN AMERICA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 233. LATIN AMERICA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 234. LATIN AMERICA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 235. EUROPE, MIDDLE EAST & AFRICA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 236. EUROPE, MIDDLE EAST & AFRICA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 237. EUROPE, MIDDLE EAST & AFRICA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 238. EUROPE, MIDDLE EAST & AFRICA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 239. EUROPE, MIDDLE EAST & AFRICA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 240. EUROPE, MIDDLE EAST & AFRICA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 241. EUROPE, MIDDLE EAST & AFRICA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY ENERGY DEVICES, 2018-2024 (USD MILLION)
  • TABLE 242. EUROPE, MIDDLE EAST & AFRICA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY ENERGY DEVICES, 2025-2032 (USD MILLION)
  • TABLE 243. EUROPE, MIDDLE EAST & AFRICA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 244. EUROPE, MIDDLE EAST & AFRICA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY INSTRUMENTS, 2025-2032 (USD MILLION)
  • TABLE 245. EUROPE, MIDDLE EAST & AFRICA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY VISUALIZATION SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 246. EUROPE, MIDDLE EAST & AFRICA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY VISUALIZATION SYSTEMS, 2025-2032 (USD MILLION)
  • TABLE 247. EUROPE, MIDDLE EAST & AFRICA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 248. EUROPE, MIDDLE EAST & AFRICA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 249. EUROPE, MIDDLE EAST & AFRICA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 250. EUROPE, MIDDLE EAST & AFRICA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 251. EUROPE, MIDDLE EAST & AFRICA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 252. EUROPE, MIDDLE EAST & AFRICA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 253. EUROPE, MIDDLE EAST & AFRICA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 254. EUROPE, MIDDLE EAST & AFRICA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 255. EUROPE MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 256. EUROPE MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 257. EUROPE MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 258. EUROPE MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 259. EUROPE MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 260. EUROPE MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 261. EUROPE MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY ENERGY DEVICES, 2018-2024 (USD MILLION)
  • TABLE 262. EUROPE MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY ENERGY DEVICES, 2025-2032 (USD MILLION)
  • TABLE 263. EUROPE MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 264. EUROPE MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY INSTRUMENTS, 2025-2032 (USD MILLION)
  • TABLE 265. EUROPE MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY VISUALIZATION SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 266. EUROPE MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY VISUALIZATION SYSTEMS, 2025-2032 (USD MILLION)
  • TABLE 267. EUROPE MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 268. EUROPE MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 269. EUROPE MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 270. EUROPE MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 271. EUROPE MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 272. EUROPE MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 273. EUROPE MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 274. EUROPE MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 275. MIDDLE EAST MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 276. MIDDLE EAST MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 277. MIDDLE EAST MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY PROCEDURE TYPE, 2